Centene reaffirms full year 2026 guidance ahead of investor summit
The managed care provider reaffirmed its expectations for full year 2026 GAAP and adjusted diluted earnings per share.
Centene Corporation (CNC) filed a regulatory report disclosing plans to participate in the Deutsche Bank 2026 Healthcare Summit on Wednesday, September 16, 2026, at 9:00 a.m. EDT. During the event and in subsequent discussions with investors through the week of September 21, management will discuss the company's financial results and reaffirm its full year guidance.
Key takeaways
- Centene reaffirmed full year 2026 GAAP diluted EPS guidance of greater than $3.11.
- The company reaffirmed full year adjusted diluted EPS guidance of greater than $4.80.
- Management will present at the Deutsche Bank 2026 Healthcare Summit on Wednesday, Sept. 16, 2026.
- Discussions with investors will continue through the week of September 21, 2026.
Guidance and financial outlook
The company stated in a filing that it maintains its previously issued financial targets for the full year 2026. The guidance includes GAAP diluted earnings per share of greater than $3.11 and adjusted diluted earnings per share of greater than $4.80.
Centene provides non-GAAP measures that exclude amortization of acquired intangible assets, acquisition and divestiture related expenses, and other items to assist investors in assessing ongoing operations. The company directs investors to its July 28, 2026, Form 8-K filing for a reconciliation of GAAP diluted EPS to adjusted diluted EPS.
Webcast and conference details
A live audio webcast of the presentation will be available online, with a replay accessible via the investor relations section of the company's website following the event.
Why it matters
The reaffirmation provides updated visibility into the company's financial trajectory for the remainder of the year as management meets with institutional investors. The guidance figures remain effective only through September 25, 2026, according to the filing, and the company stated it will not update or affirm the figures unless it issues a public announcement.
By the numbers
| Metric | Value | Source |
|---|---|---|
| Full Year 2026 GAAP Diluted EPS | Greater than $3.11 | Regulatory filing |
| Full Year 2026 Adjusted Diluted EPS | Greater than $4.80 | Regulatory filing |
| Conference Date | September 16, 2026 | Regulatory filing |
| Conference Time | 9:00 a.m. EDT | Regulatory filing |
What happens next
Management will engage with investors through the week of September 21, 2026. The guidance issued in connection with the summit will expire on September 25, 2026, after which the company has no obligation to update or affirm the figures without a separate public announcement.